Hobby Airport was one of five airports selected nationally to use a new facial recognition software. Image via fly2houston.com

International travelers coming in and out of Hobby Airport are being processed now completely with facial recognition as of last week. The technology is expected to shorten wait times and streamline safety.

"Hobby Airport has taken a big leap into the future of travel," Houston Aviation Director Mario Diaz says in a news release.

Houston was one of the five airports picked by Homeland Security — and the only in Texas — to have Simplified Arrivals, a full biometric entry and exit for international passengers going through United States Customs and Border Protection inspection checkpoints.

"Simplified Arrivals will enhance the travel experience for more than a million international passengers traveling through Hobby Airport every year," Diaz continues in the release. "This is an important step to realize our goal of becoming a 5-star airport."

Houston Airport Systems first introduced biometric technology with Southwest Airlines in November 2018, and before that, George Bush Intercontinental Airport first started using facial recognition technology in 2017. Since 2018, this biometric facial technology has recognized 250 imposters nationally who attempted to enter the U.S. with legal travel documents that belonged to a different person, according to the release.

The new technology is expected to speed up the checkpoint process. Image via fly2houston.com

Travelers will encounter the technology at their primary inspection point. They will taker a photo, which will then compare that image to previously provided photos of that traveler — like passport and visa photos. Travelers under the age of 14 or over the age of 79 can opt out and be process manually. United States and Canadian citizens may also opt out.

"CBP is committed to working with our partners to ensure that the travel system is secure and efficient," Houston Director of Field Operations Judson W. Murdock II says in the release. "The speed, accuracy and reliability of facial comparison technology enable CBP officers to confirm a traveler's identity within seconds while further enhancing the customer experience."

These new photos of U.S. citizens taken at the checkpoint will be deleted within 12 hours, while photos of foreign nationals will be stored in a secure system.

"It takes a village to make something like this happen," says Saba Abashawl, director of external affairs at HAS, in a promotional video. "At the end of the day, we end up providing unparalleled customer service."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.